Related Experiment Videos

Editorial: is surveillance for hepatocellular carcinoma really required for all British cirrhotics?

P Brennan¹, A Bathgate¹

¹Centre for Liver and Digestive Disorders, Royal Infirmary of Edinburgh, Edinburgh, UK.

Alimentary Pharmacology & Therapeutics

|April 4, 2017

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Hepatology: Emerging Paradigms in MASLD, Viral Hepatitis, Cholestatic Liver Disease, Portal Hypertension and Hepatocellular Carcinoma: Summary of the First Annual Paris International Liver Meeting 2026.

Liver international : official journal of the International Association for the Study of the Liver·2026

Progression to Decompensation of Severe Fibrosis Compared to Cirrhosis in MASLD: A Systematic Review and Meta-Analysis.

Liver international : official journal of the International Association for the Study of the Liver·2026

Guideline-directed medical strategies for the co-management of heart failure and metabolic dysfunction-associated steatotic liver disease.

Communications medicine·2025

Autologous macrophage therapy for liver cirrhosis: a phase 2 open-label randomized controlled trial.

Nature medicine·2025

A narrative review of lifestyle management guidelines for metabolic dysfunction-associated steatotic liver disease.

Hepatology (Baltimore, Md.)·2024

Increased risk of chronic kidney disease and mortality in a cohort of people diagnosed with metabolic dysfunction associated steatotic liver disease with hepatic fibrosis.

PloS one·2024

See all related articles